Abstract:A series of 4-thiazolinone derivatives (D1-D58) were designed and synthesized. All of the derivatives were evaluated in vitro for neuraminidase (NA) inhibitory activities against influenza virus A (H1N1), and the inhibitory activities of the five most potent compounds were further evaluated on NA from two different influenza viral subtypes (H3N2 and B), and then their in vitro anti-viral activities were evaluated using the cytopathic effect (CPE) reduction assay. The results showed that the majority of the target compounds exhibited moderate to good NA inhibitory activity. Compound D18 presented the most potent inhibitory activity with IC50 values of 13.06 μM against influenza H1N1 subtype. Among the selected compounds, D18 and D41 turned out to be the most potent inhibitors against influenza virus H3N2 subtype (IC50 = 15.00 μM and IC50 = 14.97 μM, respectively). D25 was the most potent compound against influenza B subtype (IC50 = 16.09 μM). In addition, D41 showed low toxicity and greater potency than reference compounds Oseltamivir and Amantadine against N1-H275Y variant in cellular assays. The structure-activity relationship (SAR) analysis showed that introducing 4-CO2H, 4-OH, 3-OCH3-4-OH substituted benzyl methylene can greatly improve the activity of 4-thiazolinones. Further SAR analysis indicated that 4-thiazolinone and ferulic acid fragments are necessary fragments of target compounds for inhibiting NA. Molecular docking was performed to study the interaction between compound D41 and the active site of NA. This study may providing important information for new drug development for anti-influenza virus including mutant influenza virus.

Discovery of Neuraminidase Inhibitors based on 3D-QSAR, Molecular Docking and MD Simulations

Design,Synthesis and Anti-influenza Activities of Novel Neuraminidase Inhibitors

Design, synthesis, bioactivity, and DFT calculation of 2-thiazolyl-hydrazone derivatives as influenza neuraminidase inhibitors

Molecular Docking, 3d-Qsar Studies, And In Silico Adme Prediction Of P-Aminosalicylic Acid Derivatives As Neuraminidase Inhibitors

Binding Site Analysis, 3D-QSAR Studies, and Molecular Design of Flavonoids Derivatives As Potent Neuraminidase Inhibitors

Design, Synthesis, and Evaluation of 3‐((4‐(t‐butyl)‐2‐(2‐benzylidenehydrazinyl)thiazol‐5‐yl)methyl)quinolin‐2(1h)‐ones As Neuraminidase Inhibitors

Pharmacophore Modeling, 3D‐QSAR Studies, and In‐silico ADME Prediction of Pyrrolidine Derivatives As Neuraminidase Inhibitors

Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico.

Novel Dual‐Site‐Binding Neuraminidase Inhibitor from Virtual Screening by Pharmacophore and Molecular Dynamics Methods

In Vitro Anti-Viral Activities and Structure-Activity Relationship Studies of Flavones and Dihydroflavone Derivatives As Influenza Virus Potential Neuraminidase Inhibitors

Discovery of Multi‐Targets Neuraminidase Inhibitor Lead Compound Against Influenza H1N1 Virus A/WSN/33 Based on QSAR, Docking, Dynamics Simulation and Network Pharmacology

Design of the Influenza Virus Inhibitors Targeting the PA Endonuclease Using 3D-QSAR Modeling, Side-Chain Hopping, and Docking.

Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors

Molecular Docking And Qsar Studies On Substituted Acyl(Thio)Urea And Thiadiazolo [2,3-Alpha] Pyrimidine Derivatives As Potent Inhibitors Of Influenza Virus Neuraminidase

QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR

Neuraminidase Pharmacophore Model Derived from Diverse Classes of Inhibitors.

Discovery of novel thiophene derivatives as potent neuraminidase inhibitors

Design, Synthesis, and Biological Activity of Thiazole Derivatives As Novel Influenza Neuraminidase Inhibitors

Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.

Qsar and Pharmacophore Studies of Thiazolidine-4-Carboxylic Acid Derivatives As Novel Influenza Neuraminidase Inhibitors Using Hqsar, Topomer Comfa and Comsia

Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.